Literature DB >> 16247463

Clusterin plays an important role in hepatocellular carcinoma metastasis.

S H Lau1, J S T Sham, D Xie, C-H Tzang, D Tang, N Ma, L Hu, Y Wang, J-M Wen, G Xiao, W-M Zhang, G K K Lau, M Yang, X-Y Guan.   

Abstract

To identify genes associated with tumor metastasis in hepatocellular carcinoma (HCC), gene expression profiles between a pair of primary HCC (H2-P) and their matched metastatic HCC (H2-M) were compared. Overexpression of clusterin (CLU) was found in H2-M cells. To determine the roles CLU played in HCC metastasis, CLU was transfected into H2-P cells. Overexpression of CLU in H2-P cells increased cell migration by twofold in vitro and formation of metastatic tumor nodules in liver by eightfold in vivo. To evaluate the correlation of CLU expression with HCC metastasis, the expression levels of CLU in HCCs were investigated using a tissue microarray (TMA) containing 104 pairs of primary HCCs and their matched metastases. The frequency of CLU overexpression increased significantly in metastatic HCCs (59.1%) compared with that in primary tumors (32.6%, P<0.001). To gain additional insight into the function of CLU, the expression profile of H2P-CLU was compared with vector-transfected H2-P cells by cDNA microarray. A total of 35 upregulated and 14 downregulated genes were detected in H2P-CLU. One of the upregulated genes known as YKL-40, which is implicated in matrix-remodeling and metastasis, was further studied using TMA. A significant correlation (P<0.001) between the expression levels of YKL-40 and CLU was observed, implying that the CLU-YKL-40 pathway may play an important role in HCC metastasis. Oncogene (2006) 25, 1242-1250. doi:10.1038/sj.onc.1209141; published online 17 October 2005.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16247463     DOI: 10.1038/sj.onc.1209141

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  59 in total

1.  Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3β signaling pathway.

Authors:  Hyoung-Oh Jun; Dong-hun Kim; Sae-Won Lee; Hye Shin Lee; Ji Hae Seo; Jeong Hun Kim; Jin Hyoung Kim; Young Suk Yu; Bon Hong Min; Kyu-Won Kim
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

Review 2.  New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma.

Authors:  Daniel Elieh Ali Komi; Tohid Kazemi; Anton Pieter Bussink
Journal:  Curr Allergy Asthma Rep       Date:  2016-08       Impact factor: 4.806

3.  CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.

Authors:  Leilei Chen; Tim Hon Man Chan; Yun-Fei Yuan; Liang Hu; Jun Huang; Stephanie Ma; Jian Wang; Sui-Sui Dong; Kwan Ho Tang; Dan Xie; Yan Li; Xin-Yuan Guan
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

4.  Plasma proteomics analysis of tamoxifen resistance in breast cancer.

Authors:  Keivan Majidzadeh-A; Javad Gharechahi
Journal:  Med Oncol       Date:  2013-10-26       Impact factor: 3.064

5.  The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma.

Authors:  Rathasapa Patarat; Shoji Riku; Pattapon Kunadirek; Natthaya Chuaypen; Pisit Tangkijvanich; Apiwat Mutirangura; Charoenchai Puttipanyalears
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

Review 6.  Hepatitis D and hepatocellular carcinoma.

Authors:  Zaigham Abbas; Minaam Abbas; Sarim Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2015-04-18

7.  Cancer cell-derived clusterin modulates the phosphatidylinositol 3'-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation.

Authors:  Hakryul Jo; Yonghui Jia; Kulandayan K Subramanian; Hidenori Hattori; Hongbo R Luo
Journal:  Mol Cell Biol       Date:  2008-05-05       Impact factor: 4.272

Review 8.  Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells.

Authors:  Katrin Eurich; Mayuko Segawa; Satoko Toei-Shimizu; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

9.  YKL-40 tissue expression and plasma levels in patients with ovarian cancer.

Authors:  Estrid V S Høgdall; Merete Ringsholt; Claus K Høgdall; Ib Jarle Christensen; Julia S Johansen; Susanne K Kjaer; Jan Blaakaer; Lene Ostenfeld-Møller; Paul A Price; Lise H Christensen
Journal:  BMC Cancer       Date:  2009-01-09       Impact factor: 4.430

10.  YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.

Authors:  R Shao; K Hamel; L Petersen; Q J Cao; R B Arenas; C Bigelow; B Bentley; W Yan
Journal:  Oncogene       Date:  2009-09-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.